APS

Latest SEC Filings & News for APS

2 most recent filings and news items mentioning APS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/APS/news?limit=20"

Pull APS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

M&AJun 30, 2026Positive

Aptose Biosciences completes acquisition by Hanmi Pharmaceutical for C$2.41 per share.

Aptose Biosciences announced the closing of the acquisition by Hanmi Pharmaceutical, delisting shares on July 3. Shareholders received C$2.41 per share, representing a 28% premium over the prior 30-day VWAP.

View filing at SEC.gov →

M&AMay 29, 2026Negative

Aptose-Hanmi deal closing delayed to June pending Korean regulatory approvals

Aptose Biosciences announced that closing of its previously announced Plan of Arrangement with Hanmi Pharmaceutical has been further delayed due to pending Korean regulatory approvals, now targeted for June. The company received an additional US$2.0 million advance from Hanmi und

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.